Sientra reports Q2 EPS (68c), consensus (43c) » 16:1808/1008/10/20
Reports Q2 revenue…
Story temporarily locked.
Sensus Healthcare upgraded to Buy from Neutral at Alliance Global Partners » 06:1708/1008/10/20
Alliance Global Partners…
Alliance Global Partners analyst Ben Haynor upgraded Sensus Healthcare to Buy from Neutral with a price target of $4.25, up from $2.40, citing the company's future opportunities and valuation. The analyst says Q2 results were ahead of expectations and believes that the Street does not fully appreciate the opportunities the acquisition of two mobile aesthetic laser companies serving the state of Florida provide Sensus. Additionally, Haynor says reimbursement changes should finally begin to benefit Sensus.
Cutera should be bought at these 'depressed levels,' says Piper Sandler » 04:5808/0708/07/20
Piper Sandler analyst…
Piper Sandler analyst Matt O'Brien encourages investors to start building positions in Cutera following the company's better than expected Q2 results. The company has the products, management team, and valuation that make it a "compelling name at these depressed levels on its stock," O'Brien tells investors in a research note. Further, Cutera continues to innovate with a new system still scheduled to hit the market during the third quarter, adds the analyst. O'Brien keeps an Overweight rating on the shares with an $18 price target.
Fly Intel: After-Hours Movers » 18:5808/0608/06/20
CNDT, TRUE, GRPN, STMP, AAOI, VXRT, SAIL, Z, ZG, TDC, UPLD, LGF, LGF.A, YELP, DXC, TLND, SWCH, OTEX, TTD, AVT, BKNG, RSG, G, MHK, UNVR, EB, TRIP, NLOK, ILMN, OLED, CLVS, DBX, CUTR, GPRO, DDOG, UBER
Check out this evening's…
Cutera names Rohan Seth CFO » 17:0508/0608/06/20
Cutera announced the…
Cutera announced the appointment of Rohan Seth as the company's Chief Financial Officer, effective August 10, 2020. Mr. Seth brings to Cutera over two decades of finance and business development experience mainly in the medical device industry. Most recently, he served as VP of Finance, Global Orthopaedics Franchise at Smith & Nephew. Prior to that, he served as the Head of Finance, U.S. Surgical at Alcon Labs where he supported a capital and recurring revenue stream business for nearly four years. Prior to his time at Alcon, Mr. Seth spent nine years at Stryker Corporation where he served in various roles across the business, including as Controller of the company's European Division.
Sensus Healthcare reports Q2 EPS (16c), consensus (18c) » 16:1808/0608/06/20
Reports Q2 revenue…
Reports Q2 revenue $1.18M, consensus $1.53M. "Our quarterly revenues continued to be negatively impacted by COVID-19, yet I am pleased with our ability to maintain strong customer ties during the pandemic as well as with recent activities that position Sensus Healthcare for significant future growth," said Joe Sardano, chairman and chief executive officer. "The acquisition of two mobile laser companies announced earlier this week and the subsequent formation of the Sensus Laser Aesthetic Solutions (SLAS) division is expected to generate base revenues of $1.0 million over the next 12 months. We also have the opportunity to layer into this division our new aesthetic lasers, which are expected to receive 510(k) clearance from the U.S. Food and Drug Administration by year-end. Together, these two acquired companies have approximately 30 lasers and six vans, and service some 150 dermatology practices across the State of Florida, including more than 500 that are not current Sensus customers. We also were attracted to this business as we expect aesthetic laser treatments to continue to grow, with demand from an aging demographic driving sales.
Cutera not providing updated guidance due to COVID uncertainty » 16:0308/0608/06/20
The company said,…
The company said, "As previously announced on April 3, 2020, Cutera has withdrawn its previously announced full-year 2020 guidance due to uncertainty over the magnitude and duration of the impacts from the COVID-19 pandemic on its financial results. The Company will not be providing updated guidance at this time."
Cutera reports Q2 EPS (67c), consensus (63c) » 16:0208/0608/06/20
Reports Q2 revenue…
Reports Q2 revenue $26.4M, consensus$20.69. "While our second quarter results were impacted by a decline in patient volumes associated with COVID-related shutdowns; I am encouraged by the recovery trends as patient volumes continue to rebound toward pre-COVID levels," commented Dave Mowry, Chief Executive Officer of Cutera. "I am pleased with our increased customer outreach efforts which we implemented during the quarter, leading to improved customer engagement and enabled us to be highly responsive, helping accounts increase their patient traffic. I am amazed by the resilience and adaptability of our customers, and proud of the Cutera team's work to steer the company and our clients through unprecedented adversity. We are continuing to manage the impacts of the pandemic effectively, and, with a recently strengthened balance sheet, we are well-positioned to drive a continued recovery in our business through the second half of the year despite the uncertain environment."
ASRT approves Sensus Healthcare's SRT systems for continuing education units » 08:4308/0508/05/20
Sensus Healthcare reports…
Sensus Healthcare reports that the American Society of Radiologic Technologists has approved Sensus Healthcare's SRT Systems for Continuing Education Units. The approval covers all three SRT systems offered by Sensus, namely the SRT-100(TM), the SRT-100+ and the SRT-100 Vision, and automatically recognizes Sensus Healthcare training as a legitimate provider for CEUs. The ASRT approval provides radiation therapists Category A credits, with 4.5 CEUs for the SRT-100 and SRT 100+, and 6.5 CEUs for the SRT-100 Vision in-person clinical trainings beginning September 1, 2020. Now that the ASRT has recognized the Company's training with CEUs, the American Registry of Radiologic Technologists automatically recognizes Sensus Healthcare training as a legitimate provider for CEUs. The ARRT requires Registered Technologists to complete and report 24 credits of approved continuing education activities every two years to maintain their registration.
Sensus Healthcare acquires two mobile aesthetic laser companies in Florida » 08:3408/0408/04/20
Sensus Healthcare announces the acquisition of two mobile aesthetic laser companies serving the State of Florida: Aesthetic Mobile Laser Services, which serves Southeast and Southwest Florida; and Aesthetic Laser Partners, which serves Central and Northern Florida. These transactions will add approximately $1.0 million in revenues over the next 12 months, assuming dermatology clinics will be at 80% of their pre-COVID-19 patient levels, and will be immediately accretive to earnings. Both were all-cash transactions and neither has any associated earn-outs or contingency payments. Additional financial terms were not disclosed. Aesthetic Mobile Laser Services and Aesthetic Laser Partners each has been in business for more than two decades and both have a high level of customer trust and satisfaction. Together they have approximately 30 lasers and six vans, and service some 150+ dermatology practices in Florida alone, including more than 500 dermatologists who are not current Sensus customers. Their lasers facilitate a wide range of in-office aesthetic dermatology procedures including facial rejuvenation, wrinkle removal, body sculpting/fat removal as well as other aesthetic applications. Related to this announcement, Sensus has named Paul Miano and Matthew Hufford to executive positions with a newly-formed division, Sensus Laser Aesthetic Solutions. Mr. Miano, previously founder at Aesthetic Mobile Laser Services, will serve as Vice President of the division, and Mr. Hufford, previously founder at Aesthetic Laser Partners, will be Regional Manager for Central and Northern Florida.